SEC Comment Letter for Cellectis S.A. (CLLS) (CIK 0001627281) (CLLS) — Nov 28, 2017

Cellectis S.A. (CLLS) (CIK 0001627281)
Date: Nov. 28, 2017 · CIK: 0001627281 · Accession: 0000000000-17-041759

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

Date

November 28, 2017

Author

Marie-Bleuenn Terrier

Form

UPLOAD

Company

Cellectis S.A. (CLLS) (CIK 0001627281)

Letter

November 28, 2017 Marie-Bleuenn Terrier General Counsel Cellectis S.A. 8, rue de la Croix Jarry 75013 Paris, France Cellectis S.A. Form 20-F for the Fiscal Year Ended December 31, 2016 Filed March 23, 2017 File No. 001-36891Re: Dear Ms. Terrier: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence by the staff. Division of Corporation Finance Office of Healthcare & Insurance

Show Raw Text

November 28, 2017
Marie-Bleuenn Terrier
General Counsel
Cellectis S.A.
8, rue de la Croix Jarry
75013 Paris, France
Cellectis S.A.
Form 20-F for the Fiscal Year Ended December 31, 2016
Filed March 23, 2017
File No. 001-36891Re:
Dear Ms. Terrier:
            We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence by the staff.
Division of Corporation Finance
Office of Healthcare & Insurance

SecProbe.io